Skip to main content
Equibles

Kathmere Capital Management, LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1794543 WAYNE, PA
Back to AUPH Full portfolio

Position in AUPH

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$296,313
+$129,692 QoQ
Shares Held
17,461
+55.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#164
of 282 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kathmere Capital Management, LLC holds $2,116,993 across 8 Biotechnology names. AUPH ranks #3 (14.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SXTP
60 Degrees Pharmaceuticals, Inc.
 265,100 $466,576
2 ARGX
Argenx SE
 366 $339,563
3 AUPH
Aurinia Pharmaceuticals Inc.
This page 		17,461 $296,313
4 URGN
UroGen Pharma Ltd.
 7,360 $270,848
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 529 $262,770
6 PBYI
Puma Biotechnology, Inc.
 31,172 $252,804
7 JAZZ
Jazz Pharmaceuticals plc
 868 $209,161
8 BDTX
Black Diamond Therapeutics, Inc.
 10,248 $18,958

All Filings in AUPH

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $296,313 17,461
2026-03-31 $166,621 11,243